Mark A. Schlossberg

Mark A. Schlossberg

Nessuna posizione attualmente
65 anni
Health Technology
Consumer Non-Durables
Consumer Services

Profilo

Mark A. Schlossberg served as an Independent Director at ImmunoCellular Therapeutics Ltd. from 2015 to 2017.
He was a Director at Angiologix, Inc. and a Vice President at Amgen, Inc. from 2004 to 2011.
He also worked as a Principal at R.J.
Reynolds Tobacco Holdings, Inc. and as a Vice President-Law at Medtronic Trading Ltd. Additionally, he served as the Secretary, Senior Vice President & General Counsel at Impax Laboratories LLC from 2012 to 2018 and as the Secretary, Senior VP-Legal & General Counsel at Cytokinetics, Inc. from 2011 to 2022.
Schlossberg received his undergraduate degree from the University of Southern California and his graduate degree from Emory University School of Law.

Precedenti posizioni note di Mark A. Schlossberg

SocietàPosizioneFine
CYTOKINETICS, INCORPORATED Consigliere Generale 13/05/2022
Consigliere Generale 01/05/2018
EOM PHARMACEUTICALS HOLDINGS, INC. Direttore/Membro del Consiglio 15/08/2017
AMGEN INC. Corporate Officer/Principal 01/05/2011
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Mark A. Schlossberg

Formazione di Mark A. Schlossberg

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

74

Relazioni di 1° grado

10

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private10

Health Technology

Consumer Non-Durables

Health Technology

Health Technology

Health Technology

Electronic Technology

Consumer Services

Medtronic Trading Ltd.

Consumer Non-Durables

Consumer Services

  1. Mercati
  2. Insiders
  3. Mark A. Schlossberg